Contemporary Lymph Node Counts During Primary Retroperitoneal Lymph Node Dissection

Laparoscopic retroperitoneal lymph node dissection.

OBJECTIVES Primary objective of the present article is to evaluate the surgical efficiency of the laparoscopic retroperitoneal lymph node dissection in clinical stage I and II testis tumor. Secundary, objective is the description of the technique used by the author. METHODS A description of the author's experience and review of the literature in terms of feasibility, oncological results and ...

Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma

Reducing the long-term morbidity in testicular cancer survivors represents a major area of interest. External beam radiation therapy and systemic chemotherapy are established treatments for seminoma; however, they are associated with late toxicities such as cardiovascular disease, insulin resistance, and secondary malignancy. Retroperitoneal lymph node dissection (RPLND) is a standard treatment...

laparoscopic retroperitoneal lymph node dissection after chemotherapy; a review

context to review and summarize the literature regarding the current status of postchemotherapy laparoscopic retroperitoneal lymph node dissection (pcl-rplnd) in patients with testicular germ cell tumor. evidence acquisition a comprehensive review of the english literature was performed using the pubmed database using the terms “laparoscopy” or “laparoscopic”, retroperitoneal lymph node dissect...

Lymph Node Dissection

Gastric cancer remains as one of the leading causes of death worldwide (Yoshida et al., 2004). Middle third and distal cancers tend to decline worldwide. However, in the western populations proximal gastric cancers tend to increase even though the incidence of those cancers stays the same in Japan. Today, the incidence of early gastric cancer has reached above 50% in Japan while in the west two...

VATS lymph node dissection.